Collaboration Details

Print  Close

Title of Collaborative Activity:

FDA-NCI Every Other Month Meeting

Description of Collaborative Activity:

An every other month meeting to enhance communication between NCI and FDA, thereby expediting the development of new anti-cancer agents.  General topics discussed include patient safety, clinical efficacy, and regulatory pathways to licensure; as well as an understanding of the operations of the sister agencies.

Type of Collaborative Activity:

Meeting/ Workshop

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: